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The product from the preceding reaction was dissolved in CH 2 Cl 2 (40 mL) and cooled to 0 ºC. To this solution, tetrabromomethane (20.3 mmol, 1.13 eq.) and triphenylphosphine (20.3 mmol, 1.13 eq.) were slowly added. After stirring for 16 hours, the reaction mixture was concentrated to approximately one quarter of the original volume and applied directly to a flash silica gel column (eluent: heptane/Et 2 O
(1:l)). Concentration of the pure fractions under reduced pressure provided 2.7 g (50% yield over two steps) of 5-(bromomethyl)-2,2'-bipyridine as a pale yellow solid.
Analytical data were in accordance with those previously published. 
Synthesis of (2,2΄-bipyridin-5-yl)alanine.
To a solution of diethyl acetaminomalonate (13.4 mmol, 1.5 eq.) and NaOEt (13.4 mmol, 1.5 eq.) in EtOH (80 mL, anhydrous), 5-(bromomethyl) 2,2´-bipyridine ( 9.0 mmol, 1.0 eq.) was added under an N 2 atmosphere. The reaction mixture was heated to reflux overnight. The solvent was evaporated under reduced pressure and the residue was purified by silica gel flash column chromatography heptane/EtOAc 1:1 (until isolation of the compound that corresponds to the first spot in the TLC) and then CH 2 Cl 2 /MeOH 9:1 to give diethyl 2-(2,2´-bipyridin-5-ylmethyl)-2-acetamidomalonate as a white solid (3.5 g, 70% Finally, a suspension of diethyl 2-(2,2´-bipyridin-5-ylmethyl)-2-acetamidomalonate (9.0 mmol) in aqueous HCl (60 mL, 37% in water) was heated to reflux overnight. The solvent was evaporated under reduced pressure to give bipyridylalanine as a white HCl salt (2.6 g, 82%), which was used in experiments without further purification.
Molecular Biology
Gene optimization:
The synthesized gene of LmrR was ordered from GenScript (USA). The codon usage was adapted to the codon bias of E. coli genes. The gene was delivered in the cloning vector pUC57, containing a C-terminal strep-tag and K55D, K55Q mutations as previously described. 4 The gene was subsequently recloned to the pET17b expression plasmid using the restriction sites NdeI and HindIII.
Optimized sequence:
Site directed mutagenesis:
Site-directed mutagenesis was used for preparation of all LmrR mutants. The primers required for the mutagenesis are summarized in Table S1 . The following PCR cycles were used: initial denaturation at 95 ⁰C for 1 min, denaturation at 95 ⁰C for 30 s, annealing at 58-63 ⁰C for 1 min (depending on the T m of the particular mutant) and extension at 68 ⁰C for 5 min. The thermal cycle was repeated 16 times. The resulting PCR product was digested with restriction endonuclease DpnI for 1h at 37 ⁰C and transformed into the E.Coli XL1-blue cells. 
Expression and purification
The plasmids pEVOL-BpyA and pET17b_LmrR_LM_X were cotransformed into E.
coli BL21 (DE3)_C43 and a single colony was used to inoculate an overnight culture of 10 mL of fresh LB medium containing 100 μg/mL of ampicillin and 34 µg/ml of chloramphenicol. 2 mL (500x dilutions) of overnight culture was used to inoculate 1 L of fresh LB medium containing 100 μg/mL of ampicillin 34 µg/ml of chloramphenicol.
When the culture reached an optical density at 600 nm of 0.8-0.9, the expression was Legend:
M-Marker (SigmaMarker ™ low range, mol wt 6500-66000 Da), FT -Flowthrough column, W -wash fraction, E -elution fraction.
Gels were stained with InstantBlue TM (Expedeon). 
